Human disease
atopic eczema
Mondo defines it as: “A common chronic pruritic inflammatory skin disease with a strong genetic component. Onset typically occurs during the first 2 years of life.”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 269 | Dermatitis, atopic | OMIA's OMIM numbers | 4 | Human disease |
40.0
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Abrocitinib | None of these genes | Approved |
| Alitretinoin | None of these genes | Approved |
| Atomoxetine | None of these genes | Approved |
| Baricitinib | None of these genes | Approved |
| Bilastine | None of these genes | Approved |
| Cortisone | None of these genes | Approved |
| Cortisone Acetate | None of these genes | Approved |
| Crisaborole | None of these genes | Approved |
| Cromolyn | None of these genes | Approved |
| Delgocitinib | None of these genes | Approved |
| Desloratadine | None of these genes | Approved |
| Desonide | None of these genes | Approved |
| Dexamethasone | None of these genes | Approved |
| Dexamethasone Phosphoric Acid | None of these genes | Approved |
| Doxepin | None of these genes | Approved |
| Dupilumab | None of these genes | Approved |
| Epinastine | None of these genes | Approved |
| Fexofenadine | None of these genes | Approved |
| Fluocinolone Acetonide | None of these genes | Approved |
| Fluticasone Propionate | None of these genes | Approved |
| Guanfacine | None of these genes | Approved |
| Hydrocortisone | None of these genes | Approved |
| Hydrocortisone Butyrate | None of these genes | Approved |
| Ipratropium | None of these genes | Approved |
| Juniper Tar | None of these genes | Approved |
| Lebrikizumab | None of these genes | Approved |
| Levocetirizine | None of these genes | Approved |
| Lisdexamfetamine | None of these genes | Approved |
| Methylphenidate | None of these genes | Approved |
| Methylprednisolone | None of these genes | Approved |
| Nemolizumab | None of these genes | Approved |
| Olopatadine | None of these genes | Approved |
| Pimecrolimus | None of these genes | Approved |
| Prednisolone | None of these genes | Approved |
| Prednisone | None of these genes | Approved |
| Promethazine | None of these genes | Approved |
| Ruxolitinib | None of these genes | Approved |
| Tacrolimus Anhydrous | None of these genes | Approved |
| Tapinarof | None of these genes | Approved |
| Tralokinumab | None of these genes | Approved |
| Upadacitinib | None of these genes | Approved |
| Aganirsen | None of these genes | Phase 3 |
| Amlitelimab | None of these genes | Phase 3 |
| Azathioprine | None of these genes | Phase 3 |
| Benzocaine | None of these genes | Phase 3 |
| Bepotastine | None of these genes | Phase 3 |
| Betamethasone | None of these genes | Phase 3 |
| Betamethasone Dipropionate | None of these genes | Phase 3 |
| Betamethasone Phosphoric Acid | None of these genes | Phase 3 |
| Betamethasone Valerate | None of these genes | Phase 3 |
| Bifidobacterium Spp. | None of these genes | Phase 3 |
| Cannabidiol | None of these genes | Phase 3 |
| Cetirizine | None of these genes | Phase 3 |
| Cimetidine | None of these genes | Phase 3 |
| Clemastine | None of these genes | Phase 3 |
| Clioquinol | None of these genes | Phase 3 |
| Clobetasone Butyrate | None of these genes | Phase 3 |
| Comekibart | None of these genes | Phase 3 |
| Cyclosporine | None of these genes | Phase 3 |
| Difamilast | None of these genes | Phase 3 |
| Difelikefalin | None of these genes | Phase 3 |
| Ergocalciferol | None of these genes | Phase 3 |
| Fusidic Acid | None of these genes | Phase 3 |
| Gentamicin | None of these genes | Phase 3 |
| Ivarmacitinib | None of these genes | Phase 3 |
| Ketotifen | None of these genes | Phase 3 |
| Methotrexate | None of these genes | Phase 3 |
| Methylprednisolone Acetate | None of these genes | Phase 3 |
| Oatmeal, Colloidal | None of these genes | Phase 3 |
| Pac-14028 | None of these genes | Phase 3 |
| Polymyxin B | None of these genes | Phase 3 |
| Prednisolone Acetate | None of these genes | Phase 3 |
| Rocatinlimab | None of these genes | Phase 3 |
| Roflumilast | None of these genes | Phase 3 |
| Stapokibart | None of these genes | Phase 3 |
| Tolnaftate | None of these genes | Phase 3 |
| Tradipitant | None of these genes | Phase 3 |
| Triamcinolone | None of these genes | Phase 3 |
| Triamcinolone Acetonide | None of these genes | Phase 3 |
| Triamcinolone Hexacetonide | None of these genes | Phase 3 |
| Urea | None of these genes | Phase 3 |
| Vehicle | None of these genes | Phase 3 |
| Etrasimod | None of these genes | Phase 2/3 |
| Human Immunoglobulin G | None of these genes | Phase 2/3 |
| Lactulose | None of these genes | Phase 2/3 |
| Palmidrol | None of these genes | Phase 2/3 |
| Sodium Chloride | None of these genes | Phase 2/3 |
| Acloproxalap | None of these genes | Phase 2 |
| Adriforant | None of these genes | Phase 2 |
| Afimkibart | None of these genes | Phase 2 |
| Alclometasone Dipropionate | None of these genes | Phase 2 |
| Ammonium Trichlorotellurate | None of these genes | Phase 2 |
| Antroquinonol | None of these genes | Phase 2 |
| Apremilast | None of these genes | Phase 2 |
| Astegolimab | None of these genes | Phase 2 |
| Atuzabrutinib | None of these genes | Phase 2 |
| Awd-12-281 | None of these genes | Phase 2 |
| Barzolvolimab | None of these genes | Phase 2 |
| Bempikibart | None of these genes | Phase 2 |
| Benralizumab | None of these genes | Phase 2 |
| Bermekimab | None of these genes | Phase 2 |
| Bimosiamose | None of these genes | Phase 2 |
| Bmx-010 | None of these genes | Phase 2 |
| Boric Acid | None of these genes | Phase 2 |
| Bosakitug | None of these genes | Phase 2 |
| Branebrutinib | None of these genes | Phase 2 |
| Brepocitinib | None of these genes | Phase 2 |
| Calcipotriene | None of these genes | Phase 2 |
| Calcitriol | None of these genes | Phase 2 |
| Camlipixant | None of these genes | Phase 2 |
| Camoteskimab | None of these genes | Phase 2 |
| Cendakimab | None of these genes | Phase 2 |
| Cephalexin Anhydrous | None of these genes | Phase 2 |
| Cholecalciferol | None of these genes | Phase 2 |
| Cis-Urocanic Acid | None of these genes | Phase 2 |
| Cobamamide | None of these genes | Phase 2 |
| Co-Trimoxazole | None of these genes | Phase 2 |
| Dihomo-Gamma-Linolenic Acid | None of these genes | Phase 2 |
| Dnk333 | None of these genes | Phase 2 |
| Doxycycline Anhydrous | None of these genes | Phase 2 |
| Efalizumab | None of these genes | Phase 2 |
| Etokimab | None of these genes | Phase 2 |
| Fb-825 | None of these genes | Phase 2 |
| Fevipiprant | None of these genes | Phase 2 |
| Fezakinumab | None of these genes | Phase 2 |
| Fluocinonide | None of these genes | Phase 2 |
| Galvokimig | None of these genes | Phase 2 |
| Gsk-1070806 | None of these genes | Phase 2 |
| Gusacitinib | None of these genes | Phase 2 |
| Gw-870086 | None of these genes | Phase 2 |
| Halobetasol Propionate | None of these genes | Phase 2 |
| Idrebormilast | None of these genes | Phase 2 |
| Ifidancitinib | None of these genes | Phase 2 |
| Itepekimab | None of these genes | Phase 2 |
| Ivermectin | None of these genes | Phase 2 |
| Jnj-39758979 | None of these genes | Phase 2 |
| Kt-474 | None of these genes | Phase 2 |
| Lepzacitinib | None of these genes | Phase 2 |
| Ligelizumab | None of these genes | Phase 2 |
| Lirentelimab | None of these genes | Phase 2 |
| Lotamilast | None of these genes | Phase 2 |
| Lunsekimig | None of these genes | Phase 2 |
| Lutikizumab | None of these genes | Phase 2 |
| Mapracorat | None of these genes | Phase 2 |
| Mepolizumab | None of these genes | Phase 2 |
| Mometasone Furoate | None of these genes | Phase 2 |
| Mosedipimod | None of these genes | Phase 2 |
| Mufemilast | None of these genes | Phase 2 |
| Naltrexone | None of these genes | Phase 2 |
| Ocankitug | None of these genes | Phase 2 |
| Octenidine | None of these genes | Phase 2 |
| Omalizumab | None of these genes | Phase 2 |
| Omiganan | None of these genes | Phase 2 |
| Ompekimig | None of these genes | Phase 2 |
| Orismilast | None of these genes | Phase 2 |
| Pegcantratinib | None of these genes | Phase 2 |
| Pitrakinra | None of these genes | Phase 2 |
| Prednicarbate | None of these genes | Phase 2 |
| Rezpegaldesleukin | None of these genes | Phase 2 |
| Rilzabrutinib | None of these genes | Phase 2 |
| Risankizumab | None of these genes | Phase 2 |
| Rose Bengal Free Acid | None of these genes | Phase 2 |
| Rosiptor | None of these genes | Phase 2 |
| Rovazolac | None of these genes | Phase 2 |
| S-777469 | None of these genes | Phase 2 |
| Secukinumab | None of these genes | Phase 2 |
| Sertaconazole | None of these genes | Phase 2 |
| Silver | None of these genes | Phase 2 |
| Soquelitinib | None of these genes | Phase 2 |
| Spesolimab | None of these genes | Phase 2 |
| Taurodeoxycholic Acid | None of these genes | Phase 2 |
| Telazorlimab | None of these genes | Phase 2 |
| Temtokibart | None of these genes | Phase 2 |
| Tezepelumab | None of these genes | Phase 2 |
| Tilrekimig | None of these genes | Phase 2 |
| Timapiprant | None of these genes | Phase 2 |
| Tofacitinib | None of these genes | Phase 2 |
| Torudokimab | None of these genes | Phase 2 |
| Tozorakimab | None of these genes | Phase 2 |
| Trimethoprim | None of these genes | Phase 2 |
| Ucenprubart | None of these genes | Phase 2 |
| Udifitimod | None of these genes | Phase 2 |
| Ustekinumab | None of these genes | Phase 2 |
| Clobetasol Propionate | None of these genes | Phase 1/2 |
| Curcumin | None of these genes | Phase 1/2 |
| Honey | None of these genes | Phase 1/2 |
| Ovatodiolide | None of these genes | Phase 1/2 |
| Pf-5212372 | None of these genes | Phase 1/2 |
| Regn-846 | None of these genes | Phase 1/2 |
| Anakinra | None of these genes | Phase 1 |
| Botulinum Toxin Type A | None of these genes | Phase 1 |
| Caffeine | None of these genes | Phase 1 |
| Cerdulatinib | None of these genes | Phase 1 |
| Clonidine | None of these genes | Phase 1 |
| Hydrocortisone Acetate | None of these genes | Phase 1 |
| Hypochlorous Acid | None of these genes | Phase 1 |
| Melrilimab | None of these genes | Phase 1 |
| Metoprolol | None of these genes | Phase 1 |
| Midazolam | None of these genes | Phase 1 |
| Omeprazole | None of these genes | Phase 1 |
| Vixarelimab | None of these genes | Phase 1 |
| Warfarin | None of these genes | Phase 1 |
| Diphenhydramine | None of these genes | Early phase 1 |
| Glutamine | None of these genes | Early phase 1 |
| Influenza Virus Vaccine | None of these genes | Early phase 1 |
| Melatonin | None of these genes | Early phase 1 |
| Resomelagon | None of these genes | Investigational new drug |
| Piperazine | None of these genes | Preclinical |
| Quinazoline | None of these genes | Preclinical |
| Acetylcysteine | None of these genes | Unknown |
| Adalimumab | None of these genes | Unknown |
| Antimony | None of these genes | Unknown |
| Aspirin | None of these genes | Unknown |
| Cholesterol | None of these genes | Unknown |
| Cravacitinib | None of these genes | Unknown |
| Diflucortolone | None of these genes | Unknown |
| Dimethindene | None of these genes | Unknown |
| Glycyrrhizin | None of these genes | Unknown |
| Influenza A Virus, Split Virion | None of these genes | Unknown |
| Lactobacillus Acidophilus | None of these genes | Unknown |
| Lidocaine | None of these genes | Unknown |
| Milpecitinib | None of these genes | Unknown |
| Montelukast | None of these genes | Unknown |
| Mucopolysaccharide Polysulfate | None of these genes | Unknown |
| Pioglitazone | None of these genes | Unknown |
| Retapamulin | None of these genes | Unknown |
| Rituximab | None of these genes | Unknown |
| Tirnovetmab | None of these genes | Unknown |
| Vitamin B12 | None of these genes | Unknown |
| Zinc Acetate Anhydrous | None of these genes | Unknown |
| Zinc Sulfate | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.